In the News

1855 News Items found
Maureen Sideris is seen smiling with her sister Marion.
Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo surgery, radiation, or chemotherapy.
Dr. Elli Papaemmanuil in her lab
Researchers have shown how CH, a blood condition related to aging, affects cancer outcomes — through a phenomenon called tumor-infiltrating clonal hematopoiesis.
A pipette inserted into a tube in a rack of test tubes
Laboratory research shows how it may be possible to develop an immunotherapy-based approach for treating aggressive forms of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
A researcher working in an MSK lab
MSK Research Highlights, April 23, 2025
New MSK research identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife. MSK clinical trials also supported the recent approval of the targeted drug larotrectinib by the FDA.
Dr. Jamie Ostroff speaks with a patient
Support
MSK specialists are working to help reduce the stigma around lung cancer and smoking, helping to ensure that all patients get the best care.
MSK physician-scientists Viviane Tabar and Lorenz Studer.
Learn how a stem cell-derived treatment shows potential for treating Parkinson's disease.
The outside of the David H. Koch Center for Cancer Care at MSK
In the Clinic
For cancer in the liver, interventional radiology techniques can be used to destroy tumors while minimizing damage to healthy liver tissue. 
MSK President and CEO Selwyn Vickers, MD, FACS, speaking from a podium
MSK is committed to helping people with cancer live healthier, more satisfying lives during and after treatment. So that people don’t just survive cancer — they thrive.
MSK exercise physiologist Dr. Jessica Scott
A New Cancer Therapy: Exercise
Learn how MSK researchers are studying ways exercise can help offset treatment side effects and control cancer.
Ovarian cancer patient Pauline with her MSK care team at the NYC marathon finish
Diagnosed with ovarian cancer at 51, Pauline Larkin feared her racing days were over — within the year, she was running in the NYC marathon with her MSK doctors by her side.